Consonance Capital Management LP / URGN
Consonance Capital Management LP’s Urogen Pharma Ltd Position
Does Consonance Capital Management LP own Urogen Pharma Ltd (URGN)? Not currently — the last reported position was 1.43M shares worth $52M in Q2 2019; the fund’s latest 13F (Q3 2022) no longer reports it.
Position Value
$52M
Q2 2019
Shares
1.43M
% of Portfolio
+3.65%
Quarters Held
2
position exited
Position History URGN
Reported value by quarter
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Consonance Capital Management LP’s full portfolio or all institutional holders of URGN.